Overview
Indications
® ® AUSTEDO XRand AUSTEDOare indicated in adults for the treatment of: 14.1 [see Clinical Studies ()] chorea associated with Huntington’s disease 14.2 [see Clinical Studies ()] tardive dyskinesia
Boxed Warning
FDA Black Box Warning
AUSTEDO XR and AUSTEDO can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease. Anyone considering the use of AUSTEDO XR or AUSTEDO must balance the risks of depression and suicidality with the clinical need for treatment of chorea.
Contraindications
When this intervention should not be used
AUSTEDO XR and AUSTEDO are contraindicated in patients: 5.1 [see Warnings and Precautions ()] With Huntington’s disease who are suicidal, or have untreated or inadequately treated depression. 8.6 12.3 [see Use in Specific Populations (), Clinical Pharmacology ()] With hepatic impairment. 7.2 [see Dr
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Deutetrabenazine (substance)
- SNOMED CT
- 733658007
- UMLS CUI
- C4277781
- RxNorm CUI
- 1876905
- Labeler
- Teva Neuroscience, Inc.
Clinical Data
This intervention maps to 1 entities in the Ltrl knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.